Skip to main content
. 2020 May 26;10(2):2045894020915832. doi: 10.1177/2045894020915832

Fig. 2.

Fig. 2.

The comparison of sST2 median level among subjects with ASD and no PH (group I), subjects with left-to-right shunt ASD and PH (group II), and subjects with ASD and Eisenmenger syndrome (group III).

sST2: soluble suppression of tumorigenicity-2.